SANA · Sana Biotechnology, Inc.
$3.91
+0.08 (+2.09%)
At close · Sep 2
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that our present capital resources may not be sufficient to fund our planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.15B
Shares
299.36M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-09 | Sana Biotechnology at the Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-03 | Sana Biotechnology at the Jefferies Global Healthcare Conference | Conference |
| 2026-05-12 | BofA Securities 2026 Healthcare Conference | Conference |
| 2026-03-11 | Sana Biotechnology at the Citizens Life Sciences Conference | Conference |
| 2026-03-02 | Sana Biotechnology at the Cowen 46th Annual Health Care Conference | Conference |
| 2025-01-07 | SANA Corporate Update Call | Webcast |
Source: https://ir.sana.com/
Key facts
CIK
1770121
CUSIP
799566104
13F (30d)
173 filings
172 filers
Visit website
Investor relations